Jessie Ehrisman

Duke Medical Center

Papers

2

Total Citations

76

H-Index

2

About

Dr. Jessie Ehrisman is a leading gynecologic oncologist whose research focuses on optimizing surgical management and outcomes for women with endometrial cancer. Her most impactful work centers on the precision and safety of sentinel lymph node (SLN) biopsy in high-risk endometrial cancer, a study that has garnered 54 citations and demonstrated that SLN mapping is a feasible and accurate alternative to complete lymphadenectomy in this complex patient population. This contribution has helped shift clinical practice toward less invasive staging. Dr. Ehrisman is also recognized for her investigation into postoperative recovery, notably her 2015 study comparing pain scores and narcotic use in robotic-assisted versus laparoscopic hysterectomy for endometrial cancer staging (22 citations). By showing that robotic surgery can reduce postoperative pain and opioid requirements, her work directly informs enhanced recovery protocols. Her research bridges the gap between surgical innovation and patient-centered care, providing evidence that improves both oncologic outcomes and quality of life. Dr. Ehrisman’s contributions continue to shape the standard of care in gynecologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
76
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Performance of sentinel lymph node biopsy in high-risk endometrial cancer
54 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Duke Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago